WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60


Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here


Track Your Article



Ch .Tarakaramarao*, K. P. R. Chowdary and P. Rajeswara Rao


Valsartan, a widely prescribed anti hypertensive drug belongs to class II under BCS classification and needs enhancement in the dissolution rate in its formulation development. The objective of the present study is optimization of Valsartan tablet formulation with NLT 85% dissolution in 10 min employing βCD, Crospovidone and SLS by 23 factorial design. The optimized valsartan tablets developed were evaluated for in vitro dissolution and in vivo pharmacokinetics. Eight valsartan tablet formulations employing selected combinations of the three Factors i.e., βCD, Crospovidone and SLS as per 23 Factorial design were formulated, prepared by direct compression method and were evaluated by in vitro and in vivo methods. Valsartan tablet formulations Fb and Fbc disintegrated rapidly with in 45 sec and gave very rapid dissolution of valsartan, 100% in 10 min. Higher levels of βCD and lower levels of Crospovidone gave low dissolution rates of valsartan tablets. The increasing order of dissolution rate (K1) observed with various formulations was F b = F bc > Fab>Fabc> Fa> Fac> F1>Fc. The polynomial equation describing the relationship between the response i.e. percent drug dissolved in 10 min (Y) and the levels of β CD (X1) , Crospovidone (X2) and SLS (X3 ) based on the observed results is Y = 60.05 + 5.34 (X1) +33.88 (X2) –8.95 (X1 X2 ) -3.18 (X3) -2.38 (X1 X3) + 2.80 (X2 X3) + 1.95 (X1 X2 X3). Based on the above polynomial equation, the optimized valsartan tablet formulation with NLT 85% dissolution in 10 min (Fopt1) could be formulated employing βCD at 1:3 ratio of drug: β CD, Crospovidone at 26.31% of drug content , and SLS at 1% of drug content.The optimized valsartan tablet formulation (Fopt1) gave 85.86 % dissolution in 10 min fulfilling the target dissolution set. In the pharmacokinetic evaluation the biological half – life (t ½) was found to be 5.06 h and 4.66 h respectively following the administration of optimized valsartan tablets formulated (Fopt2) and Market product. With both the two products tested valsartan was absorbed rapidly and peak concentration is achieved in 1 h. The absorption rate constant (Ka) was 2.275 h-1 and 1.409 h-1 respectively with Fopt2 and Market product. The relative bioavailability (BA) of valsartan from the Fopt2 formulation was 105.7 % when compared to Market product (100%).The optimized valsartan tablets formulated employing βCD, Crosspovidone and SLS (Fopt2) are comparable to the market product with regard to in vivo performance.

Keywords: Valsartan tablets, Optimization, ?-cyclodextrin, Crospovidone, SLS, Factorial Design, Pharmacokinetics.

[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More